Safety and efficacy of autologous adipose tissue-derived stem cell transplantation in aging-related low-grade inflammation patients: a single-group, open-label, phase I clinical trial.
Ngoc-Huynh Ton NguyenHao Thanh PhanPhong Minh LeLan-Huong Thi NguyenThuy Thi DoThien-Phuc Thanh PhanTrinh Van LeThanh Minh DangChinh-Nhan Lu PhanTung-Loan Thi DangNhung Hai TruongPublished in: Trials (2024)
ClinicalTrials.gov number is NCT05827757, first registered on 13th Oct 2020.
Keyphrases
- stem cell transplantation
- low grade
- clinical trial
- open label
- adipose tissue
- end stage renal disease
- high dose
- high grade
- ejection fraction
- newly diagnosed
- chronic kidney disease
- phase ii
- oxidative stress
- prognostic factors
- bone marrow
- study protocol
- type diabetes
- insulin resistance
- optical coherence tomography
- peritoneal dialysis
- phase iii
- randomized controlled trial
- high fat diet
- metabolic syndrome
- stem cells
- squamous cell carcinoma
- low dose
- cell therapy
- diabetic retinopathy
- skeletal muscle
- drug induced